Document is current
Any future updates will be listed below
-
Authors
Zollner, Linda
Torres, Diana
Briceno, Ignacio
Gilbert, Michael
Torres-Mejía, Gabriela
Dennis, Joe
Bolla, Manjeet K.
Wang, Qin
Hamann, Ute
Lorenzo Bermejo, Justo
-
Funding
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
- License Information
-
More Information
Article History
Received: 31 May 2023
Accepted: 18 September 2023
First Online: 2 October 2023
Declarations
:
: The Colombian Breast Cancer Case–Control (COL-BCCC) study and the Mexican Cancér de Mama (CAMA) study were conducted according to the guidelines laid down in the Declaration of Helsinki. All procedures involving human subjects were approved by the institutional review boards of the Pontificia Universidad Javeriana in Bogotá, Colombia and the Mexican National Institute of Public Health, respectively. Written informed consent was obtained from all study participants in advance of data and sample retrieval.
: The authors declare that they have no competing interests.
